Department of Analytical Chemistry, Nutrition and Bromatology, Faculty of Chemical Sciences, 37008 Salamanca, Spain.
Molecules. 2023 Jun 25;28(13):4978. doi: 10.3390/molecules28134978.
Contraceptive tablets typically contain a combination of two synthetic versions of an estrogen and a progestogen, which work together to inhibit the ovulation process. An accurate and precise quantification of these components is essential for contraceptive producers. In this study, we have developed the first gas chromatography-mass spectrometry (GC-MS) method for the simultaneous quantification of 17α-ethinyl estradiol (EE) and drospirenone (DP) in contraceptive formulations. Under the final working conditions, analytes were extracted from the solid by ultrasound-assisted extraction (15 min) in methanol. The resulting suspension was diluted in ethyl acetate, subjected to centrifugation and, finally, the supernatant was directly injected into the GC-MS system. No derivatization reagents were utilized. To correct for instrumental variations, calibration was performed using the internal standard method, with cholesterol as the internal standard. A good linearity was achieved throughout the calibration range for both EE (3-12 µg mL) and DP (300-1200 µg mL), with R values exceeding 0.99. Trueness, assessed in terms of percentages of recovery, was also found to be satisfactory for both analytes, with recovery rates of 106 ± 8% for EE and 93 ± 9% for DP. Furthermore, intra-day and inter-day precision studies yielded relative standard deviation values below 6% for both analytes. In terms of sensitivity, the instrumental limits of detection were 0.25 µg mL for EE and 6.6 µg mL for DP, and the instrumental limits of quantification 0.82 µg mL for EE and 22 µg mL for DP. The method was successfully applied to the analysis of contraceptive tablets from three different pharmaceutical companies. No differences were observed between the measured and the declared amount of active principle per tablet, demonstrating the applicability of the procedure. In addition, a stability study conducted on both the standards and sample extracts demonstrated that they can be stored at room temperature for a minimum period of seven days.
避孕药通常含有两种合成版本的雌激素和孕激素,它们共同作用抑制排卵过程。准确和精确地定量这些成分对于避孕药生产商至关重要。在这项研究中,我们开发了第一个同时定量测定避孕药制剂中 17α-乙炔基雌二醇(EE)和屈螺酮(DP)的气相色谱-质谱(GC-MS)方法。在最终的工作条件下,通过超声辅助提取(15 分钟)从固体中提取分析物甲醇。所得悬浮液用乙酸乙酯稀释,进行离心,最后将上清液直接注入 GC-MS 系统。未使用衍生化试剂。为了校正仪器变化,使用内标法进行校准,胆固醇作为内标。对于 EE(3-12μgmL)和 DP(300-1200μgmL),整个校准范围内均获得了良好的线性关系,R 值均超过 0.99。对于两种分析物,通过回收率的百分比评估,准确性也令人满意,EE 的回收率为 106±8%,DP 的回收率为 93±9%。此外,日内和日间精密度研究得到的两种分析物的相对标准偏差值均低于 6%。就灵敏度而言,仪器检测限为 EE 为 0.25μgmL,DP 为 6.6μgmL,仪器定量限为 EE 为 0.82μgmL,DP 为 22μgmL。该方法成功应用于三个不同制药公司的避孕药片分析。未观察到所测与每个片剂中活性成分的宣称量之间的差异,证明了该程序的适用性。此外,对标准品和样品提取物进行的稳定性研究表明,它们可以在室温下储存至少七天。